Tiantian Zhang | Health Professions | Best Researcher Award

Posted on 02/12/202402/12/2024 by ScienceFather

Dr. Tiantian Zhang | Health Professions | Best Researcher Award

Dr. Tiantian Zhang, Fudan University, China

Dr. Tiantian Zhang is a dedicated researcher in the field of public health, specializing in the construction of public health systems and proactive health technologies within the context of medical health big data. Currently serving as a Youth Researcher at the School of Public Health at Fudan University since October 2023, she brings an academic background with a Master’s and Doctorate in Management, focusing on social medicine and health management from Fudan University. She has contributed significantly to over 38 publications, with many in high-impact journals, particularly in health policy, public health emergency responses, and chronic disease prevention. Her research also covers the intersection of technology, public health, and healthcare systems. She has been involved in various research projects and has received substantial funding for her work. Dr. Zhang’s academic journey includes postdoctoral research and entrepreneurial experience in management science and data science. Additionally, she is a key member of national projects on public health and disease prevention.

Publication Profile

Scopus

Academic Background 🎓📚

Dr. Tiantian Zhang pursued her graduate studies at Fudan University, where she earned a Master’s degree in Management with a focus on Social Medicine and Health Administration from September 2016 to June 2018. 🏫🎓 She continued her academic journey at Fudan, completing a PhD in Management in the same field from June 2018 to June 2021. 🔬 Her doctoral research contributed to advancing public health management and policy, further establishing her expertise in healthcare systems and social medicine. Dr. Zhang’s academic foundation laid the groundwork for her current work in public health and health data research. 🌟📊

Professional and Visiting Scholar Experience 💼🌍

Dr. Tiantian Zhang has held various esteemed positions in her career. Since October 2023, she has been serving as a Youth Researcher at Fudan University, focusing on Health Management. 🏫🧑‍🔬 From June 2021 to September 2023, she worked as a Postdoctoral Researcher at Fudan University, specializing in Public Policy. 📜🔍 Additionally, since September 2017, Dr. Zhang has been the founder and legal representative of Shanghai Haiyu Information Technology Co., Ltd., where she applies her expertise in Management Science and Data Science. 💻📊 Her diverse roles reflect her commitment to advancing healthcare and policy through innovation. 🌟

Research Achievements and Contributions 📚🏆

Dr. Tiantian Zhang, a Youth Researcher at Fudan University’s School of Public Health, has made significant contributions to healthcare management research. She has co-authored 9 policy briefs, receiving positive feedback from top political leaders, including members of the Central Political Bureau. 👩‍🔬✨ She has led a National Natural Science Foundation Youth Project and 7 provincial projects, while also contributing to major national R&D initiatives. Her research includes 37 published papers, 8 of which are in high-impact journals (SCI/SSCI, JCR-Q1), with a total impact factor of 68.5. 📝📊 Dr. Zhang has received multiple prestigious awards, including the Shanghai Decision-Making Advisory Research Awards and the Shanghai Youth Medal. 🏅

Academic Positions and Editorial Roles 📚🌟

Dr. Tiantian Zhang holds several prestigious academic roles. She is a Youth Elite Talent for the Shanghai Municipal Government Decision-Making Consulting Research Base (2024–2026) and an expert in Shanghai’s healthcare reform (2022–2025). 🏅 She serves on the Youth Committee of the Shanghai Medical Association’s Health Management Branch and is a director of the Chinese Medicine Informatics Society. 🩺 Additionally, she contributes to several academic journals, including Chinese Hospital Management and Chinese Public Health Management, where she holds youth editorial board positions. ✍️ She is also involved in writing and editing key publications, including the fifth edition of Health Management and the Blue Book on Proactive Health and Healthy Aging. 📖

Research Focus

Dr. Tiantian Zhang’s research focuses on public health management, health policy, and health data science. She is particularly interested in the intersection of healthcare system development and technology for proactive health and aging. 🏥 Her work includes studies on health equity, air pollution, dyslipidemia, and disease prevention, and she frequently contributes to research on health disparities and socioeconomic factors affecting public health. 🌍 Additionally, she explores health management practices and decision-making frameworks for improving healthcare services, with a strong emphasis on government regulation and community-based health interventions. 📊

Publication Top Notes

Association of circadian syndrome with risk of hyperuricemia among middle-aged and older adults in China – 2025 🕰️,
Research on government regulation methods for the spatial layout of retail pharmacies – 2024 🏪
Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai – 2024 ⚖️,
Global Justice Index Report 2023 – 2024 🌍, Cited by: 2 📑.
Association of long-term exposure to air pollutants with sensory impairment in middle-aged and elderly adults – 2024 🌫️
Equity analysis of older adult resource allocation in China – 2024 💼
Development of an assessment tool for designated medical institutions in China – 2024 💻
Association of indoor solid fuel use and long-term exposure to ambient PM2.5 with sarcopenia in China – 2023 🌫️, Cited by: 10 📑.
Global Justice Index Report 2022 – 2023 🌍, Cited by: 7 📑.

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Posted on 04/11/202404/11/2024 by ScienceFather

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

Publication Top Notes

A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

Serhat Aras | Health Professions | Best Researcher Award

Posted on 30/10/202430/10/2024 by ScienceFather

Assoc. Prof. Dr. Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras, University of Health Sciences Turkey, Turkey

Assoc. Prof. Dr. Serhat Aras is a nuclear physicist with a Ph.D. from Manisa Celal Bayar University, where he focused on Monte Carlo methods in dose calculations for prostate brachytherapy. He currently serves at the University of Health Sciences, Istanbul, specializing in medical imaging and radiological sciences. Dr. Aras has led research on the radiobiological effects of advanced radiation techniques in cancer treatments, including studies on breast and lung cancer. His teaching includes courses on radiologic imaging, radiation safety, and nuclear medicine. In 2023, he received an International Research Award in India. 🧪📡👨‍🏫

Publication Profile

Google Scholar

Academic Background

Dr. Aras completed his PhD in Nuclear Physics at Celal Bayar University, focusing on advanced methodologies for calculating patient doses in prostate brachytherapy using Monte Carlo simulations. His Master’s research also focused on dose distribution in brachytherapy, providing a solid foundation for his contributions to medical physics. His specialized education enhances his capacity to innovate in patient-specific dosimetry, an essential area in clinical radiotherapy.

Professional Experience

Dr. Aras serves in the Medical Imaging Techniques Program at Istanbul Health Sciences University. His roles have included Assistant Professor and Lecturer, where he has imparted his knowledge in courses such as Radiologic Imaging Physics, Radiation Safety, and Nuclear Medicine. His expertise in radiology and medical physics makes him an asset to the field, both in research and education, as he prepares future professionals in these highly technical fields.

Research Projects

Dr. Aras has led numerous research projects in radiobiology and oncology, demonstrating his commitment to advancing medical science. His projects include the study of radiobiological impacts on non-small cell lung cancer xenografts and the protective effects of melatonin and probiotics against radiation-induced tissue damage in experimental rat models. His role as a principal investigator in these studies reflects his leadership and research aptitude, focusing on innovative approaches to radiotherapy and radiation protection.

Awards and Recognition

Dr. Aras received the 2023 International Research Award from ISSN, India, which highlights his global research impact. This accolade, along with his publication record, underscores his contributions to nuclear and medical physics on an international level.

Conclusion

Assoc. Prof. Dr. Serhat Aras’s extensive research in medical imaging, radiotherapy, and radiobiological protection, combined with his teaching and leadership roles, makes him a suitable and commendable candidate for the Best Researcher Award. His contributions to nuclear physics applications in medicine reflect both a commitment to scientific advancement and a positive impact on clinical practices.

Publication Top Notes

Dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiotherapy techniques (IMRT) with radiotherapy dose simulations for left breast cancer 💉 – Cited by: 41, Year: 2019
Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice 📏 – Cited by: 27, Year: 2020
The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy 🌙 – Cited by: 12, Year: 2021
Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat 🐭 – Cited by: 11, Year: 2020
Radiobiological comparison of flattening filter (FF) and flattening filter free (FFF) beam in rat laryngeal tissue 🔬 – Cited by: 8, Year: 2020
Home care for mastectomy patients 🏥 – Cited by: 0, Year: 2008
A survey study of radiation protection awareness among radiology technicians in Mogadishu, Somalia 🌍 – Cited by: 7, Year: 2020
Thoracic re-irradiation for locally recurrent lung cancer 🫁 – Cited by: 5, Year: 2016
The dosimetric comparison and evaluation of helical tomotherapy, volumetric-modulated arc radiotherapy (VMAT), step-and-shoot and sliding window radiotherapy techniques in breast cancer 💻 – Cited by: 4, Year: 2022
Effect of Flattening Filter and Flattening Filter Free beams on radiotherapy-induced peripheral blood cell damage ⚗️ – Cited by: 4, Year: 2021

Fei Yu | Medicine and Dentistry | Best Researcher Award

Posted on 29/10/202429/10/2024 by ScienceFather

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Nilank Shah MD | Medicine | Best Researcher Award

Posted on 22/10/202422/10/2024 by ScienceFather

Dr. Nilank Shah MD | Medicine | Best Researcher Award

Course Director and Professor, Touro College of Osteopathic Medicine, United States

An accomplished medical professional with extensive expertise in pharmacology and toxicology, this individual has dedicated their career to advancing medical education and research. They have held various prestigious positions, including Principal Investigator at TouroCOM, where they focus on organ preservation and therapeutic solutions. Their commitment to innovation in teaching methodologies and multidisciplinary research reflects a deep passion for both education and health science. 🌟

Publication Profile

Google Scholar

Education

Graduating with an MBBS from MPS Medical College & Hospital in India, they further specialized with an MD in Pharmacology and Applied Therapeutics from the same institution. Their academic journey continued with an MS in Pharmacology & Toxicology from Long Island University, USA, followed by a Post-Doctoral Fellowship in Physiology and Pharmacology at the State University of New York. Additionally, they completed certificate programs in Food & Nutrition and Nutrition & Care with first-class honors from Indira Gandhi National University. 🎓

Experience

With a robust background in both clinical practice and academia, this professional has successfully integrated teaching with research. They have developed special methodologies and new pedagogies that enhance the learning experience for students in health sciences. Their role as a Principal Investigator on multiple funded research projects at TouroCOM highlights their ability to lead impactful studies in the field. 💼

Research Focus

Their research primarily concentrates on organ preservation solutions and the therapeutic effectiveness of innovative oxygen carriers in cardiac care. This work exemplifies their commitment to advancing healthcare through rigorous scientific investigation, bridging clinical applications with cutting-edge research in pharmacology and toxicology. 🔬

Awards and Honors

This individual has received numerous accolades for their contributions to medical research and education, including several funded research grants as Principal Investigator. Their recognition underscores their role as a leader in the field and their dedication to improving health outcomes through science and education. 🏆

Publication Top Notes

“Organ Preservation Solution: A Multidisciplinary Approach” – Journal of Clinical Pharmacology (2023) Cited by 30 articles

“Therapeutic Effectiveness of OxyVita Hemoglobin Based Oxygen Carrier” – Cardiology Research (2022) Cited by 25 articles

“Advancements in Organ Transplantation: A Review” – American Journal of Transplantation (2021) Cited by 40 articles

“Innovative Teaching Methodologies in Medical Education” – Medical Education Online (2020) Cited by 15 articles

Ivan Medina | Health Professions | Best Researcher Award

Posted on 21/10/202421/10/2024 by ScienceFather

Ivan Medina | Health Professions | Best Researcher Award

Prof Ivan Medina, Universidad de Málaga, Spain

Prof. Ivan Medina-Porqueres is a distinguished expert in Physical Therapy with over 20 years of experience at the University of Malaga, where he teaches courses such as Musculoskeletal Assessment and Manual Therapy. He holds advanced master’s degrees in Sports Physiotherapy and Research in Sports & Physical Activity. With over 70 publications, his research focuses on clinical assessment, sports injuries, and innovative therapies like Platelet-Rich Plasma treatment. An active member of professional organizations, he frequently speaks at conferences, reflecting his commitment to advancing physiotherapy. Prof. Medina’s work significantly enhances clinical practice and patient care. 🎓🩺📚✨

Publication Profile

Google Scholar

Academic and Professional Background

Prof. Medina has over 20 years of experience in the field of Physical Therapy and has played a significant role in teaching courses like Musculoskeletal Assessment, Kinesiology, Anatomy, and Manual Therapy at the University of Malaga. His educational background, including advanced master’s degrees in Sports Physiotherapy, Manual Therapy, and Research in Sports & Physical Activity, establishes him as an expert in his field.

CAREER PROFILE

Experienced physical therapist with a rich academic and administrative background in university-based settings, actively involved in various sports disciplines since 1998. Demonstrates a proven ability to ensure safe, quality patient care while building productive teams and effectively managing administrative and financial tasks. Committed to achieving corporate objectives, with well-developed interpersonal skills that foster leadership in team-oriented environments. Current clinical expertise and recent publications enhance a contemporary approach to patient care, ensuring that practices remain relevant and effective. Prof. Ivan Medina-Porqueres continues to contribute positively to both academic and clinical landscapes. 🏥🎓💪📈

Research Focus

Prof. Ivan Medina-Porqueres focuses his research on the field of physiotherapy, with particular expertise in musculoskeletal injuries, sports rehabilitation, and innovative treatment modalities. His significant contributions include studies on the effectiveness of acupuncture, eccentric exercise therapy, and platelet-rich plasma in managing various conditions like shoulder impingement, osteoarthritis, and fibromyalgia. He emphasizes clinical assessment and therapeutic exercises for recovery training, addressing issues such as myofascial pain and pelvic floor health. Prof. Medina’s work is influential in advancing clinical practices and improving patient outcomes, solidifying his role as a key figure in contemporary physiotherapy research. 🏋️‍♂️📚💉💪

Publication Top Notes

Single-point acupuncture and physiotherapy for the treatment of painful shoulder: a multicentre randomized controlled trial

TENDÓN. Valoración y tratamiento en fisioterapia

Effectiveness of the eccentric exercise therapy in physically active adults with symptomatic shoulder impingement or lateral epicondylar tendinopathy: a systematic review

Anterior Cruciate Ligament Strain In Vivo: A Systematic Review

Physical examination tests for the diagnosis of femoroacetabular impingement. A systematic review

Manual de pruebas diagnosticas

En: Manual de pruebas diagnósticas

Conclusion

With his extensive experience, significant contributions to research, and dedication to education and community engagement, Prof. Ivan Medina-Porqueres is a highly deserving candidate for the Best Researcher Award. His work not only advances knowledge in physiotherapy but also enhances clinical practice and patient care.

Guanwei Fan | Cardiovascular research | Best Researcher Award

Posted on 14/10/202414/10/2024 by ScienceFather

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. 📚❤️

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

Publication Top Notes

Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-κB signaling pathway. Journal of Ethnopharmacology, 2024. 📖
Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. 📖
Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. 📖
Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. 📖
Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice. Phytomedicine, 2024. 📖
Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. 📖
Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. 📖
Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. 📖
Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. 📖
Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. 📖

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Posted on 12/10/202412/10/2024 by ScienceFather

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Prof Ashwani Singal, University of Louisville School of Medicine, United States

Prof. Ashwani Singal, he appears to be a highly suitable candidate for the Best Researcher Award. Here are several reasons supporting this nomination:

Publication Profile

Google Scholar

Research and Academic Excellence

Extensive Education: Prof. Singal holds an MBBS, MD in Medicine, and a DM in Gastroenterology, along with postdoctoral training in Transplant Hepatology and Gastroenterology from prestigious institutions like Mayo Clinic and UTMB Galveston.
Publications: He has a substantial publication record, including influential papers on liver diseases, alcoholic liver disease, and hepatitis C, demonstrating his contributions to advancing medical knowledge in his field. His work has been recognized in reputable journals and conferences, with multiple posters of distinction presented at AASLD annual conferences.

Clinical Impact

Leadership Roles: As the Medical Director of Liver Transplant at the Trager Transplant Institute and a Transplant Hepatologist at Avera Transplant Institute, he plays a critical role in clinical practice and patient care, impacting many lives.
Current Support: His involvement in multiple funded research projects indicates ongoing commitment to advancing research in alcohol use disorders and liver diseases, with significant financial backing from NIH and other organizations.

Contributions to Medical Education

Teaching and Mentoring: Prof. Singal has extensive experience in teaching medical students and residents across various institutions, having served as a course director and providing numerous lectures and grand rounds. His mentorship has led to several mentees receiving awards for their research.

Professional Engagement

Committee Involvement: He has served on numerous committees and councils within professional societies, showcasing his dedication to improving the field of gastroenterology and hepatology.
Editorial Roles: Prof. Singal is active in the editorial boards of reputable journals, contributing to the peer-review process and shaping future research directions in his specialty.

Recognition and Awards

Recent Nominations: His nomination for the Clinical Innovation Award by the Healio-American College of Gastroenterology and his status as an International Fellow of the National Academy of Medical Science in India highlight his recognition as a leader in his field.

Publication Top Notes

ACG clinical guideline: alcoholic liver disease

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Antioxidants as therapeutic agents for liver disease

Hepatitis C virus and hepatocellular carcinoma: a narrative review

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosis

Mesenteric venous thrombosis

Conclusion

Prof. Ashwani Singal’s extensive academic credentials, significant clinical contributions, commitment to education, active engagement in professional societies, and recognition in the form of awards and nominations make him an exemplary candidate for the Best Researcher Award. His work not only contributes to advancing medical knowledge but also directly impacts patient care and the training of future healthcare professionals.

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Posted on 23/09/202423/09/2024 by ScienceFather

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

Madineh Abbasi | Health Professions Award | Best Researcher Award

Posted on 30/08/202430/08/2024 by ScienceFather

Assist Prof Dr. Madineh Abbasi | Health Professions Award | Best Researcher Award

Assist Prof Dr. Madineh Abbasi, Tabriz University of Medical Sciences, Iran

Based on the provided information, Assist. Prof. Dr. Madineh Abbasi seems like a strong candidate for the Research for Best Researcher Award. Here’s an evaluation of why she might be suitable:

Publication profile

Orcid

Research Focus and Achievements

Expertise in Medical Entomology and Vector Control: Dr. Abbasi has extensive experience in medical entomology, specifically with mosquitoes and maggot therapy. Her research includes significant work on Anopheles stephensi, a major malaria vector, and she has conducted studies on insecticide resistance and the use of maggots for wound therapy. This demonstrates her expertise in both vector control and innovative medical treatments.

Innovative Techniques and Tools: Dr. Abbasi utilizes advanced tools and techniques such as MaxEnt software for ecological modeling, and she has experience with various diagnostic and research methodologies. Her involvement in modeling climate change impacts and rearing mosquitoes and maggots for therapeutic purposes underscores her innovative approach to research.

Professional Experience and Impact

Diverse Roles and Responsibilities: Dr. Abbasi has held various positions, from teaching to managing entomology labs and coordinating health programs. Her current role as an Assistant Professor at Tabriz University of Medical Sciences and her past roles highlight her broad expertise and leadership in her field.

Awards and Recognition: Her achievements, such as being first in national entrance exams and her role as the scientific focal point for invasive Aedes mosquitoes surveillance, demonstrate her exceptional academic and professional standing.

Skills and Education

Educational Background: Dr. Abbasi’s educational credentials, including a PhD in Medical Entomology and multiple degrees in related fields, provide a solid foundation for her research capabilities. Her certifications in various software and methodologies further enhance her qualifications.

Language Proficiency: Her ability to communicate in Persian, Turkish, and English broadens her capacity for international collaboration and dissemination of research findings.

Publication Top Notes

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
The Lancet (2024) | DOI: 10.1016/S0140-6736(24)00476-8 | 📝
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet Neurology (2024) | DOI: 10.1016/S1474-4422(24)00038-3 | 🧠
Prevalence of depression, anxiety, and stress and associated reasons among Iranian primary healthcare workers: a mixed method study
BMC Primary Care (2024) | DOI: 10.1186/S12875-024-02268-W | 💔
Development of a degree-day model to predict the growth of Anopheles stephensi (Diptera: Culicidae): implication for vector control management
Environmental Entomology (2023) | DOI: 10.1093/EE/NVAD092 | 🦟
Investigation of the Factors Related to Mortality and Length of Hospitalization among COVID-19 Patients in East Azerbaijan Hospitals, Iran
Journal of Research in Health Sciences (2022) | DOI: 10.34172/JRHS.2022.92 | 🏥
Clinical Pediatric Screening for COVID-19
Iranian Journal of Pediatrics (2021) | DOI: 10.5812/IJP.107780 | 🧒
The impact of climatic variables on the population dynamics of the main malaria vector, Anopheles stephensi Liston (Diptera: Culicidae), in southern Iran
Asian Pacific Journal of Tropical Medicine (2020) | DOI: 10.4103/1995-7645.291038 | 🌡️
Resistance status of main malaria vector, Anopheles stephensi Liston (Diptera: Culicidae) to insecticides in a malaria Endemic Area, Southern Iran
Asian Pacific Journal of Tropical Medicine (2019) | DOI: 10.4103/1995-7645.250344 | 🦠
Scorpions and Scorpionism in Roudan County, Southern Iran
Journal of Arthropod-Borne Diseases (2019) | WOSUID: WOS:000508554500002 | 🦂
Pharyngeal Myiasis Caused by Sheep Botfly, Oestrus ovis (Diptera: Oestridae) Larva, Tabriz, East Azarbaijan Province, Iran: a Case Report
Journal of Arthropod-Borne Diseases (2017) | WOSUID: WOS:000399725900020 | 🐑
Designing of a laboratory model for evaluation of the residual effects of deltamethrin (K-othrine WP 5%) on different surfaces against malaria vector, Anopheles stephensi (Diptera: Culicidae)
Journal of Vector Borne Diseases (2009) | WOSUID: WOS:000272647900003 | 🦠
Detection of Leishmania major In Naturally Infected Sand Flies Using Semi Nested-PCR
Iranian Journal of Public Health (2008) | WOSUID: WOS:000262164500008 | 🦟

Conclusion

Dr. Madineh Abbasi’s extensive research in medical entomology, her innovative approach to vector control, and her impactful publications make her a strong candidate for the Research for Best Researcher Award. Her professional experience and recognition in the field further reinforce her suitability for this accolade.